(1 - 6 from 21
)
Sangamo BioSciences Appoints Dr. Stephen G. Dilly to Its Board of...
www.finanznachrichten.de
"On behalf of all of our directors I am delighted to welcome Stephen Dilly to our board," said Edward Lanphier, Sangamo''s president and CEO.
Aimmune CEO Stephen Dilly to retire by end of AIMT ...thefly.com › permalinks › entry.php › AIMT-Aimmune-...
thefly.com
Aimmune announced that CEO Stephen Dilly, M.B.B.S., Ph.D., plans to retire by the end of Aimmune will initiate a search for a successor ...
sorted by relevance / date